Search

Displaying results 7811 - 7820 of 8046 in total
  1. Drug

    Archexin

    go.drugbank.com/drugs/DB05971
    Investigational

  2. Drug

    PRLX 93936

    go.drugbank.com/drugs/DB06098
    Investigational

    PRLX 93936 is selectively toxic to cancer cells.

  3. Drug

    Eldelumab

    go.drugbank.com/drugs/DB06116
    Investigational

    MDX-1100, a fully human antibody that targets IP10 (also known as CXCL10), a chemokine expressed in association with multiple inflammatory disease indications, such as rheumatoid arthritis, inflammatory bowel disease and multiple sclerosis.

  4. Drug

    XR5944

    go.drugbank.com/drugs/DB06364
    Experimental

    XR5944 is a DNA bis-intercalating anticancer drug. It has both intercalating and antineoplastic activities.

  5. Drug

    Evernimicin

    go.drugbank.com/drugs/DB06431
    Experimental

  6. Drug

    Tecastemizole

    go.drugbank.com/drugs/DB06457
    Experimental

  7. Drug

    Liatermin

    go.drugbank.com/drugs/DB06489
    Investigational

  8. Drug

    L523S

    go.drugbank.com/drugs/DB06498
    Investigational

    According to Nemunaitis J., et al, "L523S is an immunogenic lung cancer antigen that has demonstrated preclinical safety when the gene is injected intramuscularly as an expressive plasmid (pVAX/L523S) and when delivered following incorpo...

  9. Drug

    Resiquimod

    go.drugbank.com/drugs/DB06530
    Investigational

    A substance being studied in the treatment of some types of skin cancer. When put on the skin, resiquimod causes some immune cells to make certain chemicals that may help them kill tumor cells. It is also being studied to find out if add...

  10. Drug

    Siramesine

    go.drugbank.com/drugs/DB06555
    Experimental